Please login to the form below

Not currently logged in
Email:
Password:

eltombopag

This page shows the latest eltombopag news and features for those working in and with pharma, biotech and healthcare.

GSK files Revolade in hepatitis C in Europe and US

GSK files Revolade in hepatitis C in Europe and US

GlaxoSmithKline (GSK) has filed for approval of Revolade (eltombopag) in Europe and the US as a treatment for low blood platelet counts in patients with chronic hepatitis C virus infection.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics